Specific delivery of drugs to the brain

Details for Australian Patent Application No. 2004249172 (hide)

Owner Baxter International Inc.

Inventors Kipp, James E.; Gendelman, Howard E.; Rabinow, Barrett E.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2004249172

PCT Pub. Number WO2004/112747

Priority 60/482,096 24.06.03 US

Filing date 15 June 2004

Wipo publication date 29 December 2004

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

Event Publications

25 May 2006 Section 223 Application Allowed

  Baxter International Inc. The time in which to enter the National Phase has been extended to 24 Mar 2006. Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000

1 June 2006 PCT application entered the National Phase

  PCT publication WO2004/112747 Priority application(s): WO2004/112747

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249178-Substituted piperidine compounds and methods of their use

2004249170-Sanitary napkin for clean body benefit